BV
Baxalta Ventures
Corporate VCModerateBaxalta Ventures is a biotech investment fund focused on novel therapeutics, medical technologies, and more.
6
Investments
2
Exits
—
AUM
33.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Baxalta Ventures.
Investment Thesis & Strategy
Baxalta Ventures, as a corporate venture capital fund, invests in various stages of biotech companies, specifically targeting novel therapeutics and medical technologies.
Investment Activity
Deals per year over the last 3 years
1
20131
20143
2015Portfolio Companies
Selected investments from their portfolio of 6 companies
O
ObsEva
Biotech · Series B, 2015
S
Selecta Biosciences
Biotech · Series B, 2015
K
Kiadis Pharma
Biotech · Growth, 2015
X
Xeris Pharmaceuticals
Biotech · Series A, 2014
A
Audentes Therapeutics
Biotech · Series A, 2013
Frequently Asked Questions
Baxalta Ventures focuses on Series A, Series B stage investments.
Related Investors
SR One
Cambridge, United States · 144 deals
Sanofi Ventures
Cambridge, United States · 37 deals
Johnson & Johnson Innovation – JJDC
Cambridge, United States · 34 deals
Johnson & Johnson Innovation вАУ JJDC
Cambridge, United States · 34 deals
Partners HealthCare Innovation
Cambridge, United States · 1 deals
Brand Capital
Mumbai, India · 570 deals